Class II antigens and disease susceptibility
GT Nepom, MD, Ph. D - Annual review of medicine, 1995 - annualreviews.org
GT Nepom, MD, Ph. D
Annual review of medicine, 1995•annualreviews.org▪ Abstract The role for HLA typing in autoimmune disease is changing with the recognition
that HLA markers can identify patients with poor prognosis in some autoimmune disease.
Aggressive therapeutic intervention in patients with such HLA prognostic markers has the
potential to improve or prevent progressive disease outcomes in a select group of patients.
that HLA markers can identify patients with poor prognosis in some autoimmune disease.
Aggressive therapeutic intervention in patients with such HLA prognostic markers has the
potential to improve or prevent progressive disease outcomes in a select group of patients.
▪ Abstract
The role for HLA typing in autoimmune disease is changing with the recognition that HLA markers can identify patients with poor prognosis in some autoimmune disease. Aggressive therapeutic intervention in patients with such HLA prognostic markers has the potential to improve or prevent progressive disease outcomes in a select group of patients.
Annual Reviews